Chimerix Inc (CMRX)
0.9068
-0.01
(-0.76%)
USD |
NASDAQ |
Nov 22, 16:00
0.9068
0.00 (0.00%)
After-Hours: 20:00
Chimerix Total Assets (Quarterly): 158.67M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 158.67M |
| June 30, 2024 | 178.51M |
| March 31, 2024 | 194.04M |
| December 31, 2023 | 212.77M |
| September 30, 2023 | 225.28M |
| June 30, 2023 | 241.08M |
| March 31, 2023 | 258.53M |
| December 31, 2022 | 279.34M |
| September 30, 2022 | 293.88M |
| June 30, 2022 | 53.56M |
| March 31, 2022 | 65.52M |
| December 31, 2021 | 100.54M |
| September 30, 2021 | 133.40M |
| June 30, 2021 | 146.72M |
| March 31, 2021 | 158.65M |
| December 31, 2020 | 84.72M |
| September 30, 2020 | 93.50M |
| June 30, 2020 | 101.67M |
| March 31, 2020 | 107.77M |
| December 31, 2019 | 119.38M |
| September 30, 2019 | 127.75M |
| June 30, 2019 | 163.44M |
| March 31, 2019 | 177.99M |
| December 31, 2018 | 190.71M |
| Date | Value |
|---|---|
| September 30, 2018 | 198.70M |
| June 30, 2018 | 200.98M |
| March 31, 2018 | 214.90M |
| December 31, 2017 | 235.23M |
| September 30, 2017 | 246.08M |
| June 30, 2017 | 257.68M |
| March 31, 2017 | 272.41M |
| December 31, 2016 | 286.77M |
| September 30, 2016 | 297.25M |
| June 30, 2016 | 310.80M |
| March 31, 2016 | 324.24M |
| December 31, 2015 | 355.99M |
| September 30, 2015 | 391.51M |
| June 30, 2015 | 421.51M |
| March 31, 2015 | 274.12M |
| December 31, 2014 | 291.88M |
| September 30, 2014 | 194.01M |
| June 30, 2014 | 204.66M |
| March 31, 2014 | 102.15M |
| December 31, 2013 | 113.39M |
| September 30, 2013 | 120.16M |
| June 30, 2013 | 126.55M |
| March 31, 2013 | 26.33M |
| December 31, 2012 | 32.03M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
53.56M
Minimum
Jun 2022
293.88M
Maximum
Sep 2022
160.38M
Average
152.69M
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 74.36B |
| Emergent BioSolutions Inc | 1.478B |
| SIGA Technologies Inc | 195.35M |
| Tonix Pharmaceuticals Holding Corp | 94.99M |
| Geovax Labs Inc | 11.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.89M |
| Shareholders Equity (Quarterly) | 135.78M |
| Current Ratio | 6.334 |
| Net Debt Paydown Yield | 0.03% |